# Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

> **NCT07299994** · — · NOT_YET_RECRUITING · sponsor: **Sigmund Freud PrivatUniversitat** · enrollment: 462 (estimated)

## Conditions studied

- Stroke
- Thrombolysis
- DAPT(Dual Antiplatelet Therapy)
- SAPT(Single Antiplatelet Therapy)
- Acute Ischemic Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07299994
- **Lead sponsor:** Sigmund Freud PrivatUniversitat
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 462 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07299994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07299994, "Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07299994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*